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Select: Manipulating Cellular MachineryCells can bemanipulated for any number of purposes, owing to the emergence of synthetic biology
and bioengineering tools. Recent biotechnological advances have generated improved therapeu-
tics, sophisticated biosensors, and new energy sources. The findings presented in this Select high-
light innovative ways to both dissect and reconstruct various cellularmachineries and components.Microbes can be instructed to build complex
chemical networks. Image courtesy of G. Steph-
anopoulos.An Untaxing Way to Produce Taxol Precursors
Taxol (paclitaxel) is a potent anticancer therapeutic typically used to treat
breast, lung, and ovarian cancers. Historically it has been produced by
synthetic or semisynthetic routes, requiring as many as 51 synthesis steps or
the use of a plant-derived intermediate, baccatin III, respectively. Ajikumar
et al. (2010) introduce a new approach to produce Taxol: engineering the iso-
prenoid pathway in Escherichia coli. There are two pathways to consider for
Taxol biosynthesis: the native upstream isoprenoid pathway produces meta-
bolic precursors, and the downstream taxadiene pathway has been recon-
structed successfully in E. coli. To date, most groups have assumed that these
pathways are additive, without paying due attention to toxic side effects of
intermediate metabolites or competing pathways and metabolites that could
inhibit the drug production. With traditional combinatorial approaches unavail-
able for taxadiene, the team undertook a ‘‘multivariate modular pathway engi-
neering’’ approach, splitting the pathway into two individually addressable
modules. The upstream module focused on the four rate-limiting genes of the
methylerythritol phosphate pathway. The downstream module comprised the
two-gene pathway, resulting in taxadiene. By tweaking various genetic compo-
nents and expression levels in the modules, the authors were able to optimize
taxadiene production to levels 15,000-fold greater than the control, yielding
1.02 g/l (to date, the highest reported titers from metabolically engineeredmicrobes have been a modest 10 mg/l). These yields notwithstanding, the key challenge in the generation of Taxol-
producing microbes is the oxidation of taxadiene to taxadien-5a-ol via CYP450, a plant enzyme that is difficult to express
in E. coli. By generating a chimeric CYP450, the authors are able to produce the alcohol but discover drastic reductions in
taxadiene production, with concomitant increases in a pathway inhibitor, indole. Improvements to the CYP450-based oxida-
tion chemistry that converts taxadiene to taxadien-5a-ol will open the door to commercial-scale synthesis of Taxol and other
high-value terpenoids for use as chemicals or fuels.
P.K. Ajikumar et al. (2010). Science 343, 70-74.A portable fluidic device that detects
odorants can be attached to a
human-like robot. Image courtesy of
S. Takeuchi.This Cell Can Smell
Whole-cell biosensors have attracted great interest in recent years, owing to their ability
to detect environmental contaminants with high specificity and sensitivity. Misawa et al.
(2010) now show that oocytes from Xenopus laevis can also be engineered for use as
chemical sensors, detecting odorants under controlled conditions in a portable fluidic
device. Because of their large size (1 mm in diameter), oocytes have been used as
model systems in electrophysiology experiments; and, like all living systems, they can
respond to certain chemicals by converting chemical signals into an amplified current
signal, which can be detected using capillary electrodes. The authors use microinjec-
tions to introduce RNAs encoding the odorant or pheromone receptors from moths or
flies that detect bombykol, bombykal, Z11-16:Ald, or 2-heptanone. The oocytes are trap-
pedwithin amicrofluidic chamber under optimized temperature and flow conditions. The
modified oocytes can ‘‘smell’’ odorants down to a concentration of 10 nM, with variation
in sensing capabilitiesmost likely due to variability in receptor expression levels. The live-
cell sensor is also able to discriminate between bombykol and bombykal, which differ
only by a terminal alcohol or aldehyde, respectively, thereby highlighting the sensor’s
inherent specificity in detecting slight differences in chemical structures. The bio-hybrid
sensor is ultimately interfaced with a robot to demonstrate that it retains the capacity for
chemical sensing under shaking conditions to mimic ‘‘real world’’ implementation of the
technology.
N. Misawa et al. (2010). Proc. Natl. Acad. Sci. 107, 15340-15344.Cell 143, November 12, 2010 ª2010 Elsevier Inc. 491
Fast Track to Biofuels with Cellodextrin Transport
The plant cell wall is highly resistant to degradation, which poses a significant challenge to the bioethanol industry. Saccha-
romyces cerevisiae is currently the yeast-of-choice for fermenting sugars from cornstarch or sugarcane; but these yeasts are
unable to naturally ferment cellodextrins derived from plant cell walls without the assistance of cellulase cocktails containing
b-glucosidases, which release yeast-fermentable glucose. The degradation of cellodextrins exhibited by the cellulolytic
fungusNeurospora crassa has inspired Galazaka et al. (2010) to create new yeast strains for enhanced growth and production
of bioethanol. Two sugar transporters, CDT-1 and CDT-2, are important for plant-fungi symbiosis and plant degradation.
Genes encoding intracellular b-glucosidases are also widespread in fungi, attesting to their importance for optimal growth
of fungi on cellulose-derived sugars. Toward complete cellodextrin catabolism and production of lignocellulosic biofuels,
the authors re-engineered an S. cerevisiae strain to contain the functional cellodextrin transport system from N. crassa
(CDT-1, CDT-2, and a b-glucosidase, GH1-1). Simultaneous saccharification and fermentation (SSF) is typically limited by
the need for complete extracellular conversion of cellodextrin to glucose, which is then transported into the cell. For SSF
in yeast re-engineered to express cdt-1 and gh1-1, the authors bypassed this extracellular step to allow the cell to take up
cellodextrin via CDT, with intracellular conversion to glucose via b-glucosidases. The result is a biofuel-producing S. cerevi-
siae strain that sidesteps the fermentation bottleneck for lignocellulosic biomass, with yields comparable to those reported
from the bioethanol industry.
J.M. Galazka et al. (2010). Science 330, 84-86.The S. aureus cell wall is visu-
alized using a biosynthetically
incorporated small molecule
fluorophore. Image courtesy
of D. Spiegel.Redecorating the Walls
Antibiotic-resistant Staphylococcus aureus has emerged as a major public health threat, with
the number of S. aureus-infection-related deaths on the rise. Nelson et al. (2010) present an
innovative engineering approach to incorporate nonnative small molecules into the S. aureus
cell wall—a technique that could have myriad implications for imaging bacteria, engineering
organisms with novel functions, and, perhaps most importantly, discovering new therapeu-
tics. To incorporate small molecules into the bacterial cell wall, small molecules conjugated
to ‘‘cell wall sorting’’ peptides with the sequence LPETG were administered to S. aureus.
These peptide sequences were recognized by the periplasmic enzyme sortase A, which
covalently cleaves the peptide and attaches the new N terminus to lipid II in the cell wall.
The authors confirm, using immunocryoelectron microscopy and mass spectrometry, respec-
tively, that the peptides localize and covalently attach to the cell wall. Covalent attachment of
small molecules then permits the incorporation of azido groups into the cell wall, which can
undergo click reactions with alkyne groups in a manner that does not interfere with native
cellular biochemistry. Thus, the authors demonstrate the ability to functionalize the bacterial
surface with an array of reactive molecules, which could enable further perturbation andstudies of bacterial process in vitro and in vivo.
J.W. Nelson et al. (2010). ACS Chemical Biology published online October 5, 2010. 10.1021/cb100195d.High-Frequency Genes, High-Specificity Antibodies
Antigen-specific monoclonal antibodies are typically identified by screening immortalized B cells or recombinant antibody
libraries. Both in vivo and in vitro methods suffer from complex design and technical drawbacks that limit their use for rapid
and reliable antibody selection. In a recent report, Reddy et al. (2010) present an antibody isolation method that uses high-
throughput DNA sequencing to analyze the variable heavy (VH) and light (VL) gene repertoires of antibody-secreting bone
marrow plasma cells from immunized mice. Bioinformatic analysis then ranks the frequency of V genes, which permits the
identification of highly expressed VH and VL genes whose products are the most likely to be antigen specific. V genes appear-
ing at roughly the same frequency are reasoned to be expressed as a pair in the same plasma cell; these pairs are then synthe-
sized and expressed as antibody fragments in Escherichia coli or as full-length immunoglobulin in mammalian cells. An anti-
body specific for the complement protein C1s isolated using this approach demonstrated subnanomolar binding affinity and
functionality in ELISA and immunoprecipitation assays. Because this methodology relies on analysis of the V gene repertoire
from bone marrow plasma cells, which produce the most abundant type of circulating antibodies, the authors hypothesize
that this screening-free, rapid isolation approach could be used to generate therapeutic antibodies. In addition, this approach
can be extended to other B cell populations and thus allow for the generation of antibodies that are tailored to an individual
patient’s immune system.
S.T. Reddy et al. (2010). Nature Biotechnology 28, 965-969.
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